Abridge vs Accelus
Side-by-side comparison of AI visibility scores, market position, and capabilities
Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.
About
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.
Accelus is a global leader in expandable interbody spinal implant technology with 32,000+ cages implanted in 25 countries; secured new equity financing in May 2025 led by Concord Health Partners;
About
Accelus is a medical device company specializing in expandable interbody spinal implant technology. Its products include bi-directional expandable cages designed to address height, lordosis, and weight parameters during spinal fusion surgery, providing the structural stability of monolithic implants while enabling minimally invasive delivery. With more than 32,000 cages implanted across 25 countries, Accelus has established a strong international commercial presence in the spine surgery market.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.